会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 71. 发明授权
    • Phosphate surfactants
    • 磷酸盐表面活性剂
    • US08022238B2
    • 2011-09-20
    • US12408074
    • 2009-03-20
    • Sheng PengAllison Mary Yake
    • Sheng PengAllison Mary Yake
    • C07F9/02
    • C09D9/04B01F17/0035B01F17/0064C07F9/091C09D7/47C09G1/04C11D1/006
    • A compound of Formula 1 Rf-A-OP(O)(O−M+)(OROH)  Formula 1 wherein Rf is a C2 to C6 linear or branched perfluoroalkyl optionally interrupted by one, two or three ether oxygen atoms; A is (CH2CF2)m(CH2)n—, (CH2)oSO2N(CH3)(CH2)p—, O(CF2)q(CH2)r—, or OCHFCF2OE-; m is 0 to 4; n, o, p, and r are each independently 2 to 20; q is 2; E is a C2 to C20 linear or branched alkyl group optionally interrupted by oxygen, sulfur, or nitrogen atoms; a cyclic alkyl group, or a C6 to C10 aryl group; M is H or a Group I metal or an ammonium cation (NHxR2y)+ wherein R2 is a C1 to C4 alkyl, x is 0 to 4, y is 0 to 4 and x+y is 4; and R is a C2 to C60 linear or branched alkyl group optionally interrupted by hetero atoms selected from the group consisting of an oxygen, sulfur, or nitrogen atom; a cyclic alkyl; or a C6 to C10 aryl; provided that when R is greater than 8 carbons, the ratio of hetero atoms to carbon atoms is at least 1:2.
    • 式1的化合物Rf-A-OP(O)(O-M +)(OROH)式1其中Rf是任选被一个,两个或三个醚氧原子间断的C2至C6直链或支链全氟烷基; A是(CH 2 CF 2)m(CH 2)n - ,(CH 2)o SO 2 N(CH 3)(CH 2)p - ,O(CF 2)q(CH 2)r - 或OCHFCF 2 OE-; m为0〜4; n,o,p和r各自独立地为2〜20; q是2; E是任选被氧,硫或氮原子间隔的C2至C20直链或支链烷基; 环状烷基或C6〜C10芳基; M为H或I族金属或铵阳离子(NH x R 2y)+,其中R 2为C 1至C 4烷基,x为0至4,y为0至4,x + y为4; 并且R是任选地被选自氧,硫或氮原子的杂原子中断的C2至C60直链或支链烷基; 环状烷基; 或C 6〜C 10芳基; 条件是当R大于8个碳时,杂原子与碳原子的比例至少为1:2。
    • 78. 发明授权
    • Skin pore minimizers and skin elasticity improvers
    • 皮肤孔隙最小化和皮肤弹性改良剂
    • US07968607B2
    • 2011-06-28
    • US12130160
    • 2008-05-30
    • Takafumi NishijimaShinya AmanoTsutomu Fujimura
    • Takafumi NishijimaShinya AmanoTsutomu Fujimura
    • A01N31/14A61K31/08C07F9/02
    • C07F9/091A61K8/463A61K8/55A61K8/602A61K8/604A61Q19/00A61Q19/08C07C279/14
    • This invention relates to skin pore tighteners each of which comprises, as an active ingredient, a compound represented by the following formula: R1—OG   (1) wherein R1 represents an alkyl or alkenyl group having 8 to 32 carbon atoms, and OG represents a residual group obtained by removing a hydrogen atom from a hydroxyl group of a polyhydric alcohol, monosaccharide or oligosaccharide at least one hydroxyl group of which has been sulfated or phosphatized, or a salt thereof, and also to skin elasticity improvers each of which comprises, as an active ingredient, a glyceryl ether derivative represented by the following formula: wherein R1 represents the same group as defined above, and X1 and X2 each independently represents a hydrogen atom, —SO3OH or —PO(OH)2 with the proviso that X1 and X2 are not hydrogen atoms at the same time, or a salt thereof.
    • 本发明涉及一种皮肤紧密剂,它们各自包含作为活性成分的由下式表示的化合物:R1-OG(1)其中R1表示碳原子数为8〜32的烷基或烯基,OG表示 通过从至少一个羟基被硫酸化或磷酸化的多元醇,单糖或寡糖的羟基除去氢原子而获得的残基,或其盐,以及皮肤弹性改进剂,其各自包含作为 活性成分,由下式表示的甘油醚衍生物:其中R1表示与上述相同的基团,X1和X2各自独立地表示氢原子,-SO3OH或-PO(OH)2,条件是X1和 X2不同时为氢原子或其盐。